Author:
Hacker Mariana Andrea,Sales Anna Maria,Duppre Nádia Cristina,Sarno Euzenir Nunes,Moraes Milton Ozório
Abstract
AbstractReduction in incidence has been associated with the introduction of novel approaches, like chemo/immune-prophylaxis. Incidence determined through follow-up cohort studies can evaluate the implementation of these innovative policies towards control and prevention. We have assessed the incidence in our contacts cohort over past 33 years, considering the effect of demographic and clinical variables. Survival analysis was used to estimate the risk of leprosy. A total of 9024 contacts were evaluated, of which 192 developed leprosy, resulting in an overall incidence of 1.4/1000 person-years. The multivariate analysis showed that the major risk factors were (i) contact from MB index cases and (ii) consanguinity (iii) intra household contact. Lower risk was detected for contacts with BCG scar who were revaccinated. There was a significant decrease in accumulated risk between the 2011–2019 period compared with 1987, probably linked to the improvement in laboratory tools to monitor contacts, thereby providing early diagnosis of contacts at intake and reduction of transmission. Our findings suggest that a combination of contact surveillance and tracing, adequate neurodermatological examination, and availability of molecular tools is highly effective in supporting early diagnosis, while a second dose of the BCG vaccination can exert extra protection.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Turing Foundation
Novartis Foundation Leprosy Research Initiative
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Ministry of Health. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Diretrizes para vigilância, atenção e eliminação da Hanseníase como problema de saúde pública: manual técnico-operacional [recurso eletrônico]/Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis.—Brasília: (Ministério da Saúde, 2016).
2. Pescarini, J. M. et al. Socioeconomic risk markers of leprosy in high-burden countries: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 12(7), e0006622 (2018).
3. Nery, J. S. et al. Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: A population-based linkage study. Lancet Glob. Health. 7(9), e1226–e1236 (2019).
4. WHO. https://www.who.int/news-room/fact-sheets/detail/leprosy (2019).
5. Ministry of Health. Leprosy Cases, Brazil, 1990–2018. https://portalarquivos2.saude.gov.br/images/pdf/2019/julho/17/Casos-novos-de-hansen--ase-por-estados-e-regi--es--Brasil--1990-a-2018.pdf (2019).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献